Q2 2022 13F Holders as of 6/30/2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
71.9M
-
Number of holders
-
630
-
Total 13F shares, excl. options
-
68.1M
-
Shares change
-
-179K
-
Total reported value, excl. options
-
$20.5B
-
Value change
-
-$170M
-
Put/Call ratio
-
0.45
-
Number of buys
-
270
-
Number of sells
-
-363
-
Price
-
$302.37
Significant Holders of WEST PHARMACEUTICAL SERVICES INC - Common Stock (WST) as of Q2 2022
758 filings reported holding WST - WEST PHARMACEUTICAL SERVICES INC - Common Stock as of Q2 2022.
WEST PHARMACEUTICAL SERVICES INC - Common Stock (WST) has 630 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 68.1M shares
of 71.9M outstanding shares and own 94.65% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (8.83M shares), BlackRock Inc. (8.06M shares), PRICE T ROWE ASSOCIATES INC /MD/ (6.25M shares), STATE STREET CORP (3.32M shares), FRANKLIN RESOURCES INC (2.77M shares), APG Asset Management N.V. (2.4M shares), FMR LLC (2.04M shares), GEODE CAPITAL MANAGEMENT, LLC (1.44M shares), Bank of New York Mellon Corp (1.24M shares), and BAMCO INC /NY/ (1.17M shares).
This table shows the top 630 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.